Geneoscopy

About:

Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.

Website: http://www.geneoscopy.com/

Twitter/X: GeneoscopyLLC

Top Investors: Morningside Venture Investments, LabCorp, Arch Grants, Dorm Room Fund, BioGenerator

Description:

Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently, there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasive colonoscopy. Geneoscopy is changing that. It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications.